Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients

OBJECTIVES: To compare the total number of adverse events (AEs) before and after mesenchymal stromal cell (MSC) infusion in refractory JIA and to evaluate its effectiveness. METHODS: Single-centre Proof of Mechanism Phase Ib, open label intervention study in JIA patients previously failing all biolo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Rheumatology (Oxford)
Autori principali: Swart, Joost F, de Roock, Sytze, Nievelstein, Rutger A J, Slaper-Cortenbach, Ineke C M, Boelens, Jaap J, Wulffraat, Nico M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Clinical Science
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6758577/
https://ncbi.nlm.nih.gov/pubmed/31070229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez157
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi